id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02278315
|
1:14:treatment,
|
Major surgery within 6 weeks of enrollment
| 3
|
[
"Major",
"surgery",
"within",
"6",
"weeks",
"of",
"enrollment"
] |
[
1,
1,
0,
0,
0,
0,
0
] |
NCT02589938
|
19:43:treatment,
|
Have received any investigational new drug within the past 30 days or planning to receive such during the study period
| 3
|
[
"Have",
"received",
"any",
"investigational",
"new",
"drug",
"within",
"the",
"past",
"30",
"days",
"or",
"planning",
"to",
"receive",
"such",
"during",
"the",
"study",
"period"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578732
|
27:38:allergy_name,42:52:allergy_name
|
Prior hypersensitivity to Oxaliplatin or Abraxane ® that in the investigators opinion would put the patient at risk if re-exposed
| 3
|
[
"Prior",
"hypersensitivity",
"to",
"Oxaliplatin",
"or",
"Abraxane",
"®",
"that",
"in",
"the",
"investigators",
"opinion",
"would",
"put",
"the",
"patient",
"at",
"risk",
"if",
"re-exposed"
] |
[
0,
0,
0,
4,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00412594
|
,,,53:66:chronic_disease
|
New York Heart Association Classification III or IV heart disease (See Appendix I)
| 3
|
[
"New",
"York",
"Heart",
"Association",
"Classification",
"III",
"or",
"IV",
"heart",
"disease",
"(",
"See",
"Appendix",
"I",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02308202
|
6:18:chronic_disease,22:43:chronic_disease,53:62:chronic_disease,66:81:chronic_disease
|
Have neurological or psychiatric disorders, such as psychosis or bipolar illness as assessed by Structural Clinical Interview for DSM disorders (SCID)
| 3
|
[
"Have",
"neurological",
"or",
"psychiatric",
"disorders",
",",
"such",
"as",
"psychosis",
"or",
"bipolar",
"illness",
"as",
"assessed",
"by",
"Structural",
"Clinical",
"Interview",
"for",
"DSM",
"disorders",
"(",
"SCID",
")"
] |
[
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02556606
|
30:39:treatment,45:74:treatment,78:120:treatment
|
Patients currently receiving treatment with vagus nerve stimulation (VNS) or repetitive transcranial stimulation (rTMS)
| 3
|
[
"Patients",
"currently",
"receiving",
"treatment",
"with",
"vagus",
"nerve",
"stimulation",
"(",
"VNS",
")",
"or",
"repetitive",
"transcranial",
"stimulation",
"(",
"rTMS",
")"
] |
[
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02107703
|
,86:112:treatment,200:295:treatment,300:318:cancer
|
relapsed with radiologic evidence of progression more than 1 year from completion of adjuvant endocrine therapy and then subsequently relapsed with radiologic evidence of progression after receiving treatment with either an antiestrogen or an aromatase inhibitor as first-line endocrine therapy for metastatic disease
| 3
|
[
"relapsed",
"with",
"radiologic",
"evidence",
"of",
"progression",
"more",
"than",
"1",
"year",
"from",
"completion",
"of",
"adjuvant",
"endocrine",
"therapy",
"and",
"then",
"subsequently",
"relapsed",
"with",
"radiologic",
"evidence",
"of",
"progression",
"after",
"receiving",
"treatment",
"with",
"either",
"an",
"antiestrogen",
"or",
"an",
"aromatase",
"inhibitor",
"as",
"first-line",
"endocrine",
"therapy",
"for",
"metastatic",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
3,
3
] |
NCT02357784
|
7:25:chronic_disease
|
has a neurologic disease
| 3
|
[
"has",
"a",
"neurologic",
"disease"
] |
[
0,
0,
2,
2
] |
NCT03074240
|
32:40:allergy_name
|
True allergy, not sensitivity, Propofol
| 3
|
[
"True",
"allergy",
",",
"not",
"sensitivity",
",",
"Propofol"
] |
[
0,
0,
0,
0,
0,
0,
4
] |
NCT01928589
|
79:93:cancer
|
Patient must have histologically confirmed (by routine H&E staining) invasive adenocarcinoma of the breast
| 3
|
[
"Patient",
"must",
"have",
"histologically",
"confirmed",
"(",
"by",
"routine",
"H",
"&",
"E",
"staining",
")",
"invasive",
"adenocarcinoma",
"of",
"the",
"breast"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0
] |
NCT02050113
|
13:30:chronic_disease,32:42:chronic_disease,47:60:chronic_disease
|
Significant occlusive disease, tortuosity, or calcification that would prevent endovascular access
| 3
|
[
"Significant",
"occlusive",
"disease",
",",
"tortuosity",
",",
"or",
"calcification",
"that",
"would",
"prevent",
"endovascular",
"access"
] |
[
0,
2,
2,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT01631617
|
46:55:treatment,57:82:treatment,84:105:treatment,110:137:treatment,,,220:229:treatment
|
Subjects receiving or planning to receive an IND agent, ultraviolet light therapy, monoclonal antibodies, or systemic immunosuppressants within 7 days or 5 half-lives (whichever is the longer time period) of initiating treatment on this protocol
| 3
|
[
"Subjects",
"receiving",
"or",
"planning",
"to",
"receive",
"an",
"IND",
"agent",
",",
"ultraviolet",
"light",
"therapy",
",",
"monoclonal",
"antibodies",
",",
"or",
"systemic",
"immunosuppressants",
"within",
"7",
"days",
"or",
"5",
"half-lives",
"(",
"whichever",
"is",
"the",
"longer",
"time",
"period",
")",
"of",
"initiating",
"treatment",
"on",
"this",
"protocol"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT00432094
|
,,34:45:treatment,,
|
Platelets > 100 x 10^9/L without transfusion and/or a bone marrow cellularity of ≥ 20%
| 3
|
[
"Platelets",
">",
"100",
"x",
"10^9/L",
"without",
"transfusion",
"and/or",
"a",
"bone",
"marrow",
"cellularity",
"of",
"≥",
"20",
"%"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01905046
|
14:26:treatment,41:61:chronic_disease,63:95:cancer,100:131:cancer
|
Having had a prior biopsy demonstrating atypical hyperplasia, lobular carcinoma in situ (LCIS), or ductal carcinoma in situ (DCIS)
| 3
|
[
"Having",
"had",
"a",
"prior",
"biopsy",
"demonstrating",
"atypical",
"hyperplasia",
",",
"lobular",
"carcinoma",
"in",
"situ",
"(",
"LCIS",
")",
",",
"or",
"ductal",
"carcinoma",
"in",
"situ",
"(",
"DCIS",
")"
] |
[
0,
0,
0,
1,
1,
0,
2,
2,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT02758847
|
1:17:chronic_disease
|
Immunosuppressed patients
| 3
|
[
"Immunosuppressed",
"patients"
] |
[
2,
0
] |
NCT03033498
|
43:64:treatment
|
Use of any medication from the prohibited concomitant therapies
| 3
|
[
"Use",
"of",
"any",
"medication",
"from",
"the",
"prohibited",
"concomitant",
"therapies"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03069469
|
1:14:treatment,
|
Major surgery within 2 weeks of the first dose of study drug
| 3
|
[
"Major",
"surgery",
"within",
"2",
"weeks",
"of",
"the",
"first",
"dose",
"of",
"study",
"drug"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02687906
|
8:17:treatment,,
|
Use of meropenem within 48 hours of administration of study drug or 12 hours after study drug administration
| 3
|
[
"Use",
"of",
"meropenem",
"within",
"48",
"hours",
"of",
"administration",
"of",
"study",
"drug",
"or",
"12",
"hours",
"after",
"study",
"drug",
"administration"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03154580
|
93:108:treatment
|
Past-month exposure to medications that increase study risk (e.g. toxicity to major organs, asthma inhalers)
| 3
|
[
"Past-month",
"exposure",
"to",
"medications",
"that",
"increase",
"study",
"risk",
"(",
"e.g",
".",
"toxicity",
"to",
"major",
"organs",
",",
"asthma",
"inhalers",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT01967823
|
1:11:chronic_disease
|
HLA-A*0201 positive
| 3
|
[
"HLA-A",
"*",
"0201",
"positive"
] |
[
2,
2,
2,
2
] |
NCT02456857
|
1:25:cancer,31:62:cancer,64:70:cancer,75:81:cancer,
|
non-melanoma skin cancer, and carcinoma in situ of the cervix, uterus, or breast from which the patient has been disease free for =< 3 years
| 3
|
[
"non-melanoma",
"skin",
"cancer",
",",
"and",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
",",
"uterus",
",",
"or",
"breast",
"from",
"which",
"the",
"patient",
"has",
"been",
"disease",
"free",
"for",
"=",
"<",
"3",
"years"
] |
[
3,
3,
3,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02519283
|
40:59:chronic_disease
|
Unable to comply with protocol- due to psychiatric disease or distance from the hospital
| 3
|
[
"Unable",
"to",
"comply",
"with",
"protocol-",
"due",
"to",
"psychiatric",
"disease",
"or",
"distance",
"from",
"the",
"hospital"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02519140
|
16:34:treatment
|
Pts undergoing sleeve gastrectomy
| 3
|
[
"Pts",
"undergoing",
"sleeve",
"gastrectomy"
] |
[
0,
0,
1,
1
] |
NCT02565901
|
1:37:cancer,,
|
Castration resistant prostate cancer as defined by serum testosterone < 50 ng/ml
| 3
|
[
"Castration",
"resistant",
"prostate",
"cancer",
"as",
"defined",
"by",
"serum",
"testosterone",
"<",
"50",
"ng/ml"
] |
[
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03072381
|
17:61:treatment
|
currently using anticoagulation or immunosuppressive therapy
| 3
|
[
"currently",
"using",
"anticoagulation",
"or",
"immunosuppressive",
"therapy"
] |
[
0,
0,
1,
1,
1,
1
] |
NCT02276443
|
,,,68:81:chronic_disease,97:118:chronic_disease,120:135:chronic_disease,139:169:chronic_disease,
|
Patients with a history of New York Heart Association class 3 or 4 heart failure, or history of myocardial infarction, unstable angina or cerebrovascular accident (CVA) within 6 months of protocol registration
| 3
|
[
"Patients",
"with",
"a",
"history",
"of",
"New",
"York",
"Heart",
"Association",
"class",
"3",
"or",
"4",
"heart",
"failure",
",",
"or",
"history",
"of",
"myocardial",
"infarction",
",",
"unstable",
"angina",
"or",
"cerebrovascular",
"accident",
"(",
"CVA",
")",
"within",
"6",
"months",
"of",
"protocol",
"registration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03112902
|
1:12:chronic_disease
|
sleep apnea
| 3
|
[
"sleep",
"apnea"
] |
[
2,
2
] |
NCT02694029
|
1:25:chronic_disease
|
unstable angina pectoris
| 3
|
[
"unstable",
"angina",
"pectoris"
] |
[
2,
2,
2
] |
NCT02359097
|
63:78:allergy_name,80:98:allergy_name,100:123:allergy_name,128:171:allergy_name
|
Subjects with known allergic or hypersensitivity reactions to parenteral iron, parenteral dextran, parenteral iron-dextran, or parenteral iron-polysaccharide preparations
| 3
|
[
"Subjects",
"with",
"known",
"allergic",
"or",
"hypersensitivity",
"reactions",
"to",
"parenteral",
"iron",
",",
"parenteral",
"dextran",
",",
"parenteral",
"iron-dextran",
",",
"or",
"parenteral",
"iron-polysaccharide",
"preparations"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02576912
|
12:20:treatment
|
Exposed to cannabis at least once in lifetime
| 3
|
[
"Exposed",
"to",
"cannabis",
"at",
"least",
"once",
"in",
"lifetime"
] |
[
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02389465
|
4:23:chronic_disease
|
No renal insufficiency
| 3
|
[
"No",
"renal",
"insufficiency"
] |
[
0,
2,
2
] |
NCT03187379
|
27:47:treatment
|
patients undergoing other bariatric procedures
| 3
|
[
"patients",
"undergoing",
"other",
"bariatric",
"procedures"
] |
[
0,
0,
0,
1,
1
] |
NCT02836574
|
14:30:chronic_disease,36:59:chronic_disease,64:87:chronic_disease,96:130:chronic_disease
|
positive for active infection with Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV), and/or Human Immunodeficiency Virus (HIV) as assessed at the Screening Visit
| 3
|
[
"positive",
"for",
"active",
"infection",
"with",
"Hepatitis",
"B",
"Virus",
"(",
"HBV",
")",
",",
"or",
"Hepatitis",
"C",
"Virus",
"(",
"HCV",
")",
",",
"and/or",
"Human",
"Immunodeficiency",
"Virus",
"(",
"HIV",
")",
"as",
"assessed",
"at",
"the",
"Screening",
"Visit"
] |
[
0,
0,
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02338999
|
28:39:chronic_disease,41:52:chronic_disease,54:57:chronic_disease,61:73:chronic_disease
|
Chronic infections such as hepatitis B, hepatitis C, HIV or Tuberculosis
| 3
|
[
"Chronic",
"infections",
"such",
"as",
"hepatitis",
"B",
",",
"hepatitis",
"C",
",",
"HIV",
"or",
"Tuberculosis"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
0,
2
] |
NCT03059004
|
1:24:treatment
|
Intra-articular therapy in last 4 weeks
| 3
|
[
"Intra-articular",
"therapy",
"in",
"last",
"4",
"weeks"
] |
[
1,
1,
0,
0,
0,
0
] |
NCT02729350
|
5:8:chronic_disease
|
Has SCD diagnosis
| 3
|
[
"Has",
"SCD",
"diagnosis"
] |
[
0,
2,
0
] |
NCT02235857
|
30:44:treatment,,105:124:treatment,318:331:treatment
|
Currently being administered ACE inhibitors that cannot be withheld for at least 24 hours prior to each apheresis treatment (Note: The time period to withhold ACE inhibitors should be prolonged, if determined by the treating physician, considering each individual's renal function and the biological half-life of the ACE-inhibitor currently in use.)
| 3
|
[
"Currently",
"being",
"administered",
"ACE",
"inhibitors",
"that",
"can",
"not",
"be",
"withheld",
"for",
"at",
"least",
"24",
"hours",
"prior",
"to",
"each",
"apheresis",
"treatment",
"(",
"Note",
":",
"The",
"time",
"period",
"to",
"withhold",
"ACE",
"inhibitors",
"should",
"be",
"prolonged",
",",
"if",
"determined",
"by",
"the",
"treating",
"physician",
",",
"considering",
"each",
"individual",
"'s",
"renal",
"function",
"and",
"the",
"biological",
"half-life",
"of",
"the",
"ACE-inhibitor",
"currently",
"in",
"use",
".",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02543983
|
64:78:treatment,80:98:treatment,100:128:treatment,133:151:treatment,153:169:treatment,174:193:treatment
|
Participants with metal objects implanted in the body, such as aneurysm clips, neural stimulators, implanted cardiac pacemakers, or auto-defibrillator, cochlear implant, or ocular foreign body which would make having an MRI scan unsafe
| 3
|
[
"Participants",
"with",
"metal",
"objects",
"implanted",
"in",
"the",
"body",
",",
"such",
"as",
"aneurysm",
"clips",
",",
"neural",
"stimulators",
",",
"implanted",
"cardiac",
"pacemakers",
",",
"or",
"auto-defibrillator",
",",
"cochlear",
"implant",
",",
"or",
"ocular",
"foreign",
"body",
"which",
"would",
"make",
"having",
"an",
"MRI",
"scan",
"unsafe"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02990455
|
27:35:chronic_disease,37:45:chronic_disease,50:64:chronic_disease
|
Self-report of history of seizures, delirium, or hallucinations during alcohol withdrawal
| 3
|
[
"Self-report",
"of",
"history",
"of",
"seizures",
",",
"delirium",
",",
"or",
"hallucinations",
"during",
"alcohol",
"withdrawal"
] |
[
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
0,
0,
0
] |
NCT03179449
|
26:40:treatment
|
Contraindication to MRI (metal implants)
| 3
|
[
"Contraindication",
"to",
"MRI",
"(",
"metal",
"implants",
")"
] |
[
0,
0,
0,
0,
1,
1,
0
] |
NCT02975869
|
1:23:cancer
|
Primary refractory AML
| 3
|
[
"Primary",
"refractory",
"AML"
] |
[
3,
3,
3
] |
NCT02338999
|
16:40:treatment,,
|
Receipt of any investigational new drug or device within 30 days prior to screening or 5 half-lives of the agent <TAB>(whichever is longer), or any investigational new drug with known long-term effects
| 3
|
[
"Receipt",
"of",
"any",
"investigational",
"new",
"drug",
"or",
"device",
"within",
"30",
"days",
"prior",
"to",
"screening",
"or",
"5",
"half-lives",
"of",
"the",
"agent",
"<",
"TAB",
">",
"(",
"whichever",
"is",
"longer",
")",
",",
"or",
"any",
"investigational",
"new",
"drug",
"with",
"known",
"long-term",
"effects"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02724540
|
1:29:treatment
|
transpapillary biliary stent
| 3
|
[
"transpapillary",
"biliary",
"stent"
] |
[
1,
1,
1
] |
NCT02931110
|
1:13:treatment
|
fondaparinux
| 3
|
[
"fondaparinux"
] |
[
1
] |
NCT02493257
|
12:29:treatment
|
History of sinonasal surgery
| 3
|
[
"History",
"of",
"sinonasal",
"surgery"
] |
[
0,
0,
1,
1
] |
NCT02414269
|
,,218:228:treatment,,,,
|
Subjects and their partners with reproductive potential must agree to use an effective form of contraception during the period of drug administration and for 4 weeks after completion of the last administration of the study drug. An effective form of contraception is defined as oral contraceptives plus 1 form of barrier or double-barrier method contraception (condom with spermicide or condom with diaphragm)
| 3
|
[
"Subjects",
"and",
"their",
"partners",
"with",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"an",
"effective",
"form",
"of",
"contraception",
"during",
"the",
"period",
"of",
"drug",
"administration",
"and",
"for",
"4",
"weeks",
"after",
"completion",
"of",
"the",
"last",
"administration",
"of",
"the",
"study",
"drug",
".",
"An",
"effective",
"form",
"of",
"contraception",
"is",
"defined",
"as",
"oral",
"contraceptives",
"plus",
"1",
"form",
"of",
"barrier",
"or",
"double-barrier",
"method",
"contraception",
"(",
"condom",
"with",
"spermicide",
"or",
"condom",
"with",
"diaphragm",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01625923
|
12:30:chronic_disease
|
History of hepatic impairment
| 3
|
[
"History",
"of",
"hepatic",
"impairment"
] |
[
0,
0,
2,
2
] |
NCT02428205
|
66:83:treatment
|
Any of the following exclusionary criteria related to the use of electrocardiogram (history of rash from adhesives)
| 3
|
[
"Any",
"of",
"the",
"following",
"exclusionary",
"criteria",
"related",
"to",
"the",
"use",
"of",
"electrocardiogram",
"(",
"history",
"of",
"rash",
"from",
"adhesives",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02522468
|
1:35:chronic_disease
|
Multifocal or multicentric disease
| 3
|
[
"Multifocal",
"or",
"multicentric",
"disease"
] |
[
2,
2,
2,
2
] |
NCT02459119
|
,,,121:131:treatment
|
Women of childbearing potential must have a negative serum pregnancy test performed within 7 days prior to the start of study drug
| 3
|
[
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"performed",
"within",
"7",
"days",
"prior",
"to",
"the",
"start",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02519322
|
,,,68:89:treatment
|
Absolute neutrophil count (ANC) >= 1.5 X 10^9/L (within 28 days of first study treatment)
| 3
|
[
"Absolute",
"neutrophil",
"count",
"(",
"ANC",
")",
">",
"=",
"1.5",
"X",
"10^9/L",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT00670358
|
4:28:chronic_disease,59:66:treatment,88:111:chronic_disease
|
No congestive heart failure requiring ongoing maintenance therapy for life-threatening ventricular arrhythmias
| 3
|
[
"No",
"congestive",
"heart",
"failure",
"requiring",
"ongoing",
"maintenance",
"therapy",
"for",
"life-threatening",
"ventricular",
"arrhythmias"
] |
[
0,
2,
2,
2,
0,
0,
0,
1,
0,
0,
2,
2
] |
NCT02078102
|
1:20:cancer
|
Follicular lymphoma (any grade)
| 3
|
[
"Follicular",
"lymphoma",
"(",
"any",
"grade",
")"
] |
[
3,
3,
0,
0,
0,
0
] |
NCT03019367
|
1:8:chronic_disease
|
Hydrops
| 3
|
[
"Hydrops"
] |
[
2
] |
NCT02446457
|
14:274:treatment,266:274:treatment,286:296:treatment,322:326:treatment
|
Has received prior therapy with an anti-programmed cell death 1 (PD-1), anti-programmed cell death ligand 1 (PD-L1), anti-programmed cell death ligand 2 (PD-L2), anti- cluster of differentiation (CD)137, or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways)
| 3
|
[
"Has",
"received",
"prior",
"therapy",
"with",
"an",
"anti-programmed",
"cell",
"death",
"1",
"(",
"PD-1",
")",
",",
"anti-programmed",
"cell",
"death",
"ligand",
"1",
"(",
"PD-L1",
")",
",",
"anti-programmed",
"cell",
"death",
"ligand",
"2",
"(",
"PD-L2",
")",
",",
"anti-",
"cluster",
"of",
"differentiation",
"(",
"CD",
")",
"137",
",",
"or",
"anti-cytotoxic",
"T-lymphocyte-associated",
"antigen-4",
"(",
"CTLA-4",
")",
"antibody",
"(",
"including",
"ipilimumab",
"or",
"any",
"other",
"antibody",
"or",
"drug",
"specifically",
"targeting",
"T-cell",
"co-stimulation",
"or",
"checkpoint",
"pathways",
")"
] |
[
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697371
|
8:19:treatment,,
|
use of transfusion or other intervention to achieve Hgb ≥ 8.0 is acceptable
| 3
|
[
"use",
"of",
"transfusion",
"or",
"other",
"intervention",
"to",
"achieve",
"Hgb",
"≥",
"8.0",
"is",
"acceptable"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697371
|
7:26:cancer,38:47:cancer,64:92:cancer,
|
Prior invasive malignancy other than liver met primary (except non-melanomatous skin cancer) unless disease free for > 3years
| 3
|
[
"Prior",
"invasive",
"malignancy",
"other",
"than",
"liver",
"met",
"primary",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
")",
"unless",
"disease",
"free",
"for",
">",
"3years"
] |
[
0,
3,
3,
0,
0,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464878
|
38:58:treatment
|
other technical reasons that require graft pancreatectomy
| 3
|
[
"other",
"technical",
"reasons",
"that",
"require",
"graft",
"pancreatectomy"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT02252588
|
8:19:cancer,,85:99:treatment,103:118:treatment
|
Active lung cancer or history of lung cancer if it has been less than 2 years since lung resection or other treatment
| 3
|
[
"Active",
"lung",
"cancer",
"or",
"history",
"of",
"lung",
"cancer",
"if",
"it",
"has",
"been",
"less",
"than",
"2",
"years",
"since",
"lung",
"resection",
"or",
"other",
"treatment"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02053246
|
1:28:chronic_disease
|
Decompensated heart failure
| 3
|
[
"Decompensated",
"heart",
"failure"
] |
[
2,
2,
2
] |
NCT02131467
|
1:17:chronic_disease
|
Active infection
| 3
|
[
"Active",
"infection"
] |
[
2,
2
] |
NCT02823665
|
8:13:chronic_disease,15:19:chronic_disease,21:26:chronic_disease,28:44:chronic_disease,48:62:chronic_disease
|
Active heart, lung, liver, gastrointestinal or kidney disease
| 3
|
[
"Active",
"heart",
",",
"lung",
",",
"liver",
",",
"gastrointestinal",
"or",
"kidney",
"disease"
] |
[
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
2
] |
NCT02847988
|
1:16:chronic_disease
|
Cardiopulmonary Instability
| 3
|
[
"Cardiopulmonary",
"Instability"
] |
[
2,
0
] |
NCT01620216
|
39:62:chronic_disease,72:95:chronic_disease,97:121:chronic_disease,126:145:chronic_disease
|
Any history of clinically significant ventricular arrhythmias (such as ventricular tachycardia, ventricular fibrillation, or torsades de pointes)
| 3
|
[
"Any",
"history",
"of",
"clinically",
"significant",
"ventricular",
"arrhythmias",
"(",
"such",
"as",
"ventricular",
"tachycardia",
",",
"ventricular",
"fibrillation",
",",
"or",
"torsades",
"de",
"pointes",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT02347891
|
1:15:treatment,
|
Pulse steroids 2 months prior to Screening
| 3
|
[
"Pulse",
"steroids",
"2",
"months",
"prior",
"to",
"Screening"
] |
[
1,
1,
0,
0,
0,
0,
0
] |
NCT01494662
|
58:76:cancer,113:123:cancer,144:160:treatment
|
Patients without pathologic or cytologic confirmation of metastatic disease should have unequivocal evidence of metastasis by physical exam or radiologic study
| 3
|
[
"Patients",
"without",
"pathologic",
"or",
"cytologic",
"confirmation",
"of",
"metastatic",
"disease",
"should",
"have",
"unequivocal",
"evidence",
"of",
"metastasis",
"by",
"physical",
"exam",
"or",
"radiologic",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
1,
1
] |
NCT02516670
|
5:56:chronic_disease
|
Has glucose-6-phosphate dehydrogenase (G6PD) deficiency
| 3
|
[
"Has",
"glucose-6-phosphate",
"dehydrogenase",
"(",
"G6PD",
")",
"deficiency"
] |
[
0,
2,
2,
2,
2,
0,
0
] |
NCT02863809
|
29:55:treatment
|
including fever and current treatment with antibiotics
| 3
|
[
"including",
"fever",
"and",
"current",
"treatment",
"with",
"antibiotics"
] |
[
0,
0,
0,
0,
1,
1,
1
] |
NCT01648023
|
21:31:cancer,54:80:cancer,85:137:cancer
|
Presence of another malignancy with the exception of cervical carcinoma in situ and stage I basal or squamous cell carcinoma of the skin
| 3
|
[
"Presence",
"of",
"another",
"malignancy",
"with",
"the",
"exception",
"of",
"cervical",
"carcinoma",
"in",
"situ",
"and",
"stage",
"I",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT01648023
|
6:27:chronic_disease,34:42:chronic_disease,46:51:cancer
|
Main portal vein occlusion (e.g. thrombus or tumor)
| 3
|
[
"Main",
"portal",
"vein",
"occlusion",
"(",
"e.g",
".",
"thrombus",
"or",
"tumor",
")"
] |
[
0,
2,
2,
2,
0,
0,
0,
2,
0,
3,
0
] |
NCT02019940
|
32:46:chronic_disease
|
Clinical evidence of untreated hypothyroidism
| 3
|
[
"Clinical",
"evidence",
"of",
"untreated",
"hypothyroidism"
] |
[
0,
0,
0,
0,
2
] |
NCT02343042
|
1:33:chronic_disease
|
Uncontrolled active hypertension
| 3
|
[
"Uncontrolled",
"active",
"hypertension"
] |
[
2,
2,
2
] |
NCT02271919
|
42:75:treatment,
|
Current enrollment or plans to enroll in another smoking cessation program in the next 12 months
| 3
|
[
"Current",
"enrollment",
"or",
"plans",
"to",
"enroll",
"in",
"another",
"smoking",
"cessation",
"program",
"in",
"the",
"next",
"12",
"months"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02600156
|
1:26:cancer
|
Clinical stage T1c or T2a
| 3
|
[
"Clinical",
"stage",
"T1c",
"or",
"T2a"
] |
[
3,
3,
3,
3,
3
] |
NCT02826343
|
12:33:chronic_disease,
|
History of respiratory infection within 2 weeks prior to the MR scan
| 3
|
[
"History",
"of",
"respiratory",
"infection",
"within",
"2",
"weeks",
"prior",
"to",
"the",
"MR",
"scan"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03072381
|
12:18:treatment
|
concurrent opioid use for pain
| 3
|
[
"concurrent",
"opioid",
"use",
"for",
"pain"
] |
[
0,
1,
0,
0,
0
] |
NCT03145298
|
15:22:chronic_disease
|
Patients with PAH-HIV
| 3
|
[
"Patients",
"with",
"PAH-HIV"
] |
[
0,
0,
2
] |
NCT03028831
|
1:8:chronic_disease
|
hepatic
| 3
|
[
"hepatic"
] |
[
2
] |
NCT02313753
|
1:21:chronic_disease,,
|
Cognitive impairment which would interfere with adequate participation in the project (MMSE< 20)
| 3
|
[
"Cognitive",
"impairment",
"which",
"would",
"interfere",
"with",
"adequate",
"participation",
"in",
"the",
"project",
"(",
"MMSE",
"<",
"20",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02555280
|
,21:30:chronic_disease,,
|
Visual Analog Scale back pain score of at least 50 mm on a 100 mm scale
| 3
|
[
"Visual",
"Analog",
"Scale",
"back",
"pain",
"score",
"of",
"at",
"least",
"50",
"mm",
"on",
"a",
"100",
"mm",
"scale"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02299414
|
26:46:chronic_disease
|
Known secondary cause of chronic hypertension
| 3
|
[
"Known",
"secondary",
"cause",
"of",
"chronic",
"hypertension"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02200445
|
29:46:chronic_disease
|
Positive screening test for tuberculosis (TB)
| 3
|
[
"Positive",
"screening",
"test",
"for",
"tuberculosis",
"(",
"TB",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT02056288
|
1:12:chronic_disease
|
Sleep apnea by polysomnography
| 3
|
[
"Sleep",
"apnea",
"by",
"polysomnography"
] |
[
2,
2,
0,
0
] |
NCT02431806
|
1:16:chronic_disease
|
Suicide attempt within the past year
| 3
|
[
"Suicide",
"attempt",
"within",
"the",
"past",
"year"
] |
[
2,
2,
0,
0,
0,
0
] |
NCT02108860
|
1:10:chronic_disease,,,,,,,,
|
Cytopenia: platelet count < 100,000/mm3, white blood cell count (WBC) < 3,000/mm3 (3 x 109/L), absolute neutrophil count < 1500/mm3, hemoglobin (Hgb) < 8.5 g/dL
| 3
|
[
"Cytopenia",
":",
"platelet",
"count",
"<",
"100,000/mm3",
",",
"white",
"blood",
"cell",
"count",
"(",
"WBC",
")",
"<",
"3,000/mm3",
"(",
"3",
"x",
"109/L",
")",
",",
"absolute",
"neutrophil",
"count",
"<",
"1500/mm3",
",",
"hemoglobin",
"(",
"Hgb",
")",
"<",
"8.5",
"g/dL"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02947347
|
1:32:cancer
|
Central nervous system lymphoma
| 3
|
[
"Central",
"nervous",
"system",
"lymphoma"
] |
[
3,
3,
3,
3
] |
NCT02594111
|
1:15:treatment
|
clarithromycin
| 3
|
[
"clarithromycin"
] |
[
1
] |
NCT01880567
|
17:20:cancer
|
Newly diagnosed MCL: Understand and voluntarily sign an IRB-approved informed consent form
| 3
|
[
"Newly",
"diagnosed",
"MCL",
":",
"Understand",
"and",
"voluntarily",
"sign",
"an",
"IRB-approved",
"informed",
"consent",
"form"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01861106
|
1:11:treatment
|
Filgrastim may be secreted in human milk, although its bioavailability from this source is not known
| 3
|
[
"Filgrastim",
"may",
"be",
"secreted",
"in",
"human",
"milk",
",",
"although",
"its",
"bioavailability",
"from",
"this",
"source",
"is",
"not",
"known"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00928356
|
39:51:treatment
|
Anatomy and body habitus suitable for Robotic CABG
| 3
|
[
"Anatomy",
"and",
"body",
"habitus",
"suitable",
"for",
"Robotic",
"CABG"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03144245
|
1:28:treatment,
|
Prior allogeneic transplant < 3 months prior to start date of AMV564
| 3
|
[
"Prior",
"allogeneic",
"transplant",
"<",
"3",
"months",
"prior",
"to",
"start",
"date",
"of",
"AMV564"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02563678
|
1:15:chronic_disease,,
|
Morbidly obese (body mass index > 40 kg/m2)
| 3
|
[
"Morbidly",
"obese",
"(",
"body",
"mass",
"index",
">",
"40",
"kg/m2",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01962415
|
1:14:chronic_disease
|
IPEX syndrome
| 3
|
[
"IPEX",
"syndrome"
] |
[
2,
2
] |
NCT03009981
|
1:37:treatment,44:56:treatment,58:77:treatment,79:89:treatment,94:140:treatment,151:162:treatment,166:178:treatment
|
Prior treatment with CYP17 inhibitor (e.g. ketoconazole, abiraterone acetate, galeterone) or second generation androgen receptor antagonist including apalutamide or enzalutamide
| 3
|
[
"Prior",
"treatment",
"with",
"CYP17",
"inhibitor",
"(",
"e.g",
".",
"ketoconazole",
",",
"abiraterone",
"acetate",
",",
"galeterone",
")",
"or",
"second",
"generation",
"androgen",
"receptor",
"antagonist",
"including",
"apalutamide",
"or",
"enzalutamide"
] |
[
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
1,
1,
1,
0,
1,
0,
1
] |
NCT02349958
|
39:49:cancer,,85:109:cancer,148:157:allergy_name,159:170:allergy_name,175:185:allergy_name
|
Patients with any evidence of another malignancy within the last five years (except non-melanoma skin cancer) Patients with a known sensitivity to cisplatin, Mitomycin C, or Adriamycin
| 3
|
[
"Patients",
"with",
"any",
"evidence",
"of",
"another",
"malignancy",
"within",
"the",
"last",
"five",
"years",
"(",
"except",
"non-melanoma",
"skin",
"cancer",
")",
"Patients",
"with",
"a",
"known",
"sensitivity",
"to",
"cisplatin",
",",
"Mitomycin",
"C",
",",
"or",
"Adriamycin"
] |
[
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
4,
0,
0,
4
] |
NCT00338377
|
5:31:chronic_disease,42:65:treatment,67:88:chronic_disease,104:121:chronic_disease,129:143:chronic_disease,145:156:chronic_disease,160:173:chronic_disease,,,335:347:treatment,348:361:treatment
|
Any active systemic infections requiring intravenous antibiotics, coagulation disorders or other major medical illnesses of the cardiovascular, respiratory or immune system, such as abnormal stress test and/or abnormal PFT. PI or his designee shall make the final determination regarding appropriateness of enrollment.(Turnstile II - Chemotherapy/Cell Infusion Exclusion Criteria)
| 3
|
[
"Any",
"active",
"systemic",
"infections",
"requiring",
"intravenous",
"antibiotics",
",",
"coagulation",
"disorders",
"or",
"other",
"major",
"medical",
"illnesses",
"of",
"the",
"cardiovascular",
",",
"respiratory",
"or",
"immune",
"system",
",",
"such",
"as",
"abnormal",
"stress",
"test",
"and/or",
"abnormal",
"PFT",
".",
"PI",
"or",
"his",
"designee",
"shall",
"make",
"the",
"final",
"determination",
"regarding",
"appropriateness",
"of",
"enrollment",
".",
"(",
"Turnstile",
"II",
"-",
"Chemotherapy/Cell",
"Infusion",
"Exclusion",
"Criteria",
")"
] |
[
0,
2,
2,
2,
0,
1,
1,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02251431
|
83:103:treatment,107:113:treatment,121:133:treatment
|
Patient is enrolled in another experimental protocol which involves the use of an investigational drug or device, or an intervention that would interfere with the conduct of the trial
| 3
|
[
"Patient",
"is",
"enrolled",
"in",
"another",
"experimental",
"protocol",
"which",
"involves",
"the",
"use",
"of",
"an",
"investigational",
"drug",
"or",
"device",
",",
"or",
"an",
"intervention",
"that",
"would",
"interfere",
"with",
"the",
"conduct",
"of",
"the",
"trial"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02140554
|
27:40:chronic_disease
|
suspected of arising from liver disease
| 3
|
[
"suspected",
"of",
"arising",
"from",
"liver",
"disease"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02469857
|
,61:75:chronic_disease
|
Patient who has been operated at least once for the current NSTI infection and had a curative deep tissue debridement
| 3
|
[
"Patient",
"who",
"has",
"been",
"operated",
"at",
"least",
"once",
"for",
"the",
"current",
"NSTI",
"infection",
"and",
"had",
"a",
"curative",
"deep",
"tissue",
"debridement"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02152956
|
,53:74:treatment
|
prior treatment failure with at least two cycles of hypomethylating agent
| 3
|
[
"prior",
"treatment",
"failure",
"with",
"at",
"least",
"two",
"cycles",
"of",
"hypomethylating",
"agent"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.